MedTrace Logo

Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril

NCT01258764 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2015-05-20

No results posted yet for this study

Summary

The purpose of this trial is to evaluate if an objective clinical decision of anti-hypertensive therapy can be made using an N-of-1 (single patient) trial design.

Conditions

  • Hypertension, Grade 1
  • Hypertension Treatment
  • N of 1 Study Design
  • Hypertension

Interventions

DRUG

Lisinopril

Lisinopril 10 mg oral, once daily for four week cycle and a 2 week cycle

DRUG

Hydrochlorothiazide

Hydrochlorothiazide 25 mg oral, once daily for 4 week cycle and a 2 week cycle

Sponsors & Collaborators

  • Scripps Translational Science Institute

    lead OTHER

Principal Investigators

  • Bradley Patay, MD · Scripps Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01258764 on ClinicalTrials.gov